Last reviewed · How we verify
Placebo of ofloxacine — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of ofloxacine (Placebo of ofloxacine) — Assistance Publique - Hôpitaux de Paris. This drug is a placebo, meaning it has no active pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of ofloxacine TARGET | Placebo of ofloxacine | Assistance Publique - Hôpitaux de Paris | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of ofloxacine CI watch — RSS
- Placebo of ofloxacine CI watch — Atom
- Placebo of ofloxacine CI watch — JSON
- Placebo of ofloxacine alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of ofloxacine — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-ofloxacine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab